Recruiting Mobile Health and Wearable Devices for Diabetes Complication Management NCT07129148 Conditions Diabetes Complications, Diabetes Mellitus, Diabetes Mellitus Complications, +6 more Locations Second Xiangya Hospital of Central South University — Changsha, China View Trial Details
Completed Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis NCT02357420 Conditions Diabetes Complications, Diabetes Mellitus, Diabetes Mellitus Complications, +14 more Locations Digestive Health Specialist of the Southeast — Dothan, Alabama, United States Huntsville, Alabama, United States Desert Sun Clinical Research — Tucson, Arizona, United States Adobe Clinical Research — Tucson, Arizona, United States View all 98 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis NCT01571297 Conditions Diabetes Complications, Diabetes Mellitus, Diabetes Mellitus Complications, +12 more Locations Dothan, Alabama, United States Tucson, Arizona, United States North Little Rock, Arkansas, United States Concord, California, United States View all 30 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis NCT01394055 Conditions Autoimmune Diseases, Diabetes Complications, Diabetes Mellitus, +17 more Locations Mayo Clinic — Rochester, Minnesota, United States View Trial Details
